SepDx Overview
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
SepDx General Information
Description
Developer of a mobile-based electronic checklist and decision-support application designed to treat sepsis. The company's application tracks patient treatment, offers prioritization of patients based on risk meeting and also facilitates easy handoff during care transition to diagnose and treat sepsis, enabling clinicians to improve patient outcomes and decrease healthcare costs through streamlined management.
Contact Information
Website
www.sepsisdx.comCorporate Office
- 291 Humphrey Street
- Unit 1
- New Haven, CT 06511
- United States
Corporate Office
- 291 Humphrey Street
- Unit 1
- New Haven, CT 06511
- United States
SepDx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | Completed | Out of Business | ||||
2. Accelerator/Incubator | 01-Jan-2017 | Completed | Startup | |||
1. Accelerator/Incubator | 10-Aug-2016 | Completed | Startup |
SepDx FAQs
-
Who is the founder of SepDx?
Ankur Kapdia, David Kaufman, Melissa Davis MD, and Prashant Krishnakumar are the founders of SepDx.
-
Where is SepDx headquartered?
SepDx is headquartered in New Haven, CT.
-
What industry is SepDx in?
SepDx’s primary industry is Decision/Risk Analysis.
-
Is SepDx a private or public company?
SepDx is a Private company.
-
What is SepDx’s current revenue?
The current revenue for SepDx is
. -
How much funding has SepDx raised over time?
SepDx has raised $15K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »